Announcements Trials

Browse Landscape

Phase

Status

Completed 18 Recruiting 5 Active not recruiting 2 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 8 Lymphoma, Follicular 7 Leukemia 7 Prostatic Neoplasms 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large B-Cell, Diffuse 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Glioblastoma 3 Burkitt Lymphoma 3 Astrocytoma 3 Stomach Neoplasms 2 Rectal Neoplasms 2 Neoplasms, Plasma Cell 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Myeloid, Chronic-Phase 2 Colonic Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Brain Neoplasms 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1

Interventions

Cyclophosphamide 6 Isotretinoin 5 thymoglobulin 4 fludarabine phosphate 4 fludarabine 4 aldesleukin 4 Topotecan 4 Temozolomide 4 Melphalan 4 Irinotecan 4 Etoposide 4 ribociclib 3 Thiotepa 3 Interleukin-2 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Busulfan 3 Bone Marrow Transplantation 3 Antilymphocyte Serum 3 temsirolimus 2 omburtamab I-131 2 dinutuximab 2 Vincristine 2 Tretinoin 2 TPI-287 2 Stem Cell Transplantation 2 Rituximab 2 Radiotherapy 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neuroblastoma × sargramostim × Clear all

NCT02641782 2022-11-04

NB2013-HR

University of Cologne

Phase 2 Terminated

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡